Literature DB >> 18836134

Cognitive deficits and reduced insight in primary progressive aphasia.

Sarah Jane Banks1, Sandra Weintraub.   

Abstract

Primary progressive aphasia (PPA) is a form of dementia caused by frontotemporal lobar degeneration. Unlike aphasia due to stroke, in which the association between particular aphasia profiles and insight has been well characterized, this relationship has not been investigated in PPA. Reduced insight is seen in other neurological conditions, but tends to involve right hemisphere damage, whereas PPA is predominantly a left hemisphere disorder. The aim of the current study was to examine whether fluent aphasia with less meaningful speech output, associated with diminished insight in stroke, is also characteristic of PPA patients with reduced insight. Fourteen PPA patients were studied. Results indicated that reduced information content in speech and poor performance on a nonlanguage test, the Pyramids and Palm Trees test, predicted reduced insight. This study has implications for the anatomical network involved in insight and clinical implications in terms of selecting interventions appropriate for individual patients with PPA.

Entities:  

Mesh:

Year:  2008        PMID: 18836134      PMCID: PMC2743890          DOI: 10.1177/1533317508320351

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  27 in total

1.  Jargon aphasia.

Authors:  R COHN; M A NEUMANN
Journal:  J Nerv Ment Dis       Date:  1958-11       Impact factor: 2.254

2.  Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia.

Authors:  A Kertesz; W Davidson; H Fox
Journal:  Can J Neurol Sci       Date:  1997-02       Impact factor: 2.104

3.  Functional neuroanatomy of semantic memory: recognition of semantic associations.

Authors:  P T Ricci; B J Zelkowicz; R D Nebes; C C Meltzer; M A Mintun; J T Becker
Journal:  Neuroimage       Date:  1999-01       Impact factor: 6.556

Review 4.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.

Authors:  D Neary; J S Snowden; L Gustafson; U Passant; D Stuss; S Black; M Freedman; A Kertesz; P H Robert; M Albert; K Boone; B L Miller; J Cummings; D F Benson
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

5.  Anosognosia in aphasics.

Authors:  Y Lebrun
Journal:  Cortex       Date:  1987-06       Impact factor: 4.027

6.  Unawareness of disease following lesions of the right hemisphere: anosognosia for hemiplegia and anosognosia for hemianopia.

Authors:  E Bisiach; G Vallar; D Perani; C Papagno; A Berti
Journal:  Neuropsychologia       Date:  1986       Impact factor: 3.139

7.  Cortical blindness with anosognosia subsequent simultaneous agnosia and persistent gross recent memory defect.

Authors:  J B Morley; F N Cox
Journal:  Proc Aust Assoc Neurol       Date:  1974

Review 8.  Primary progressive aphasia--differentiation from Alzheimer's disease.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

9.  Study of anosognosia.

Authors:  J Cutting
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-06       Impact factor: 10.154

10.  Slowly progressive aphasia without generalized dementia.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1982-06       Impact factor: 10.422

View more
  3 in total

1.  Neuropsychiatric symptoms in primary progressive aphasia: phenomenology, pathophysiology, and approach to assessment and treatment.

Authors:  Mandana Modirrousta; Bruce H Price; Bradford C Dickerson
Journal:  Neurodegener Dis Manag       Date:  2013-04-01

2.  Generalized and symptom-specific insight in behavioral variant frontotemporal dementia and primary progressive aphasia.

Authors:  Sarah Jane Banks; Sandra Weintraub
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

Review 3.  [Chronic progressive aphasia].

Authors:  J Diehl-Schmid; C Knels; A Danek
Journal:  Nervenarzt       Date:  2009-12       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.